14 Oct, 2021

CIRCULOGENE Announces Lab Expansion in Florida

FOR IMMEDIATE RELEASE CIRCULOGENE Announces Lab Expansion in Florida Liquid Biopsy Company Laboratory Operations Are Growing in Pensacola  BIRMINGHAM, Ala. and Pensacola, Fla. (October 14, 2021) – CIRCULOGENE, an innovative medical technology company transforming precision medicine through the [...]

4 Oct, 2021

CIRCULOGENE Announces Appointment of Richard B. Lanman, M.D., to Board of Directors

FOR IMMEDIATE RELEASECIRCULOGENE Announces Appointment of Richard B. Lanman, M.D., to Board of Directors BIRMINGHAM, Ala. (October 4, 2021)– CIRCULOGENE, an innovative liquid biopsy company transforming precision medicine through the rapid delivery of actionable results, [...]

26 May, 2021

CIRCULOGENE Announces Issuance of U.S. Patent for Method of Preparing Cell-Free Nucleic Acid Molecules by In Situ Amplification

Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification, enabling “in situ” genetic manipulation of biofluid samples. BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine [...]

22 May, 2020

Free Webinar: Drawing NGS Plasma at Time of Lung Biopsy

  CIRCULOGENE Free Webinar Drawing NGS Plasma at Time of Lung Biopsy, To Do or Not To Do Jun 3, 2020 7:00PM Eastern Time Please join us for this free educational webinar where our panel [...]

21 Apr, 2020

Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology

 Cell-Free DNA Concentration Associated with Injury Severity and Survival  in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology   cfDNA levels correlate significantly with biomarkers of multiorgan damage in first abstract stemming from DOD research grant to [...]

17 Mar, 2020

CIRCULOGENE’s response to COVID-19

Dear All – I want to start this by saying Thank You! to all of our clients and staff members.  Each day – with your efforts – you help hundreds of patients by giving them [...]

17 Jun, 2019

CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury

$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel. BIRMINGHAM, Ala.--(BUSINESS [...]

25 Mar, 2019

CIRCULOGENE’s Precision Genomic Profiling Technology Featured in Three AACR 2019 Abstracts

Posters present data on utility of cfDNA for patient mutation load in NSCLC; cfRNA PD-L1 + MSI single-blood-tube testing; and innovative salvage of buccal NGS testing BIRMINGHAM, Ala.--(BUSINESS WIRE)-- CIRCULOGENE, advancing precision medicine through personalized [...]

19 Feb, 2019

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through molecular genetics testing, has named Anthony L. Schmidt, M.D., F.A.C.P., as Medical Director. Dr. Schmidt will lead the [...]

13 Feb, 2019

CIRCULOGENE Molecular Diagnostics Laboratory Receives College of American Pathologists (CAP) Accreditation

 BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its molecular diagnostics laboratory has received College of American Pathologists (CAP) accreditation based on a recent on-site inspection as part [...]